144 related articles for article (PubMed ID: 19003389)
1. Justification of continuous packed-bed reactor for retroviral vector production from amphotropic PsiCRIP murine producer cell.
Kang SH; Kim BG; Lee GM
Cytotechnology; 2000 Oct; 34(1-2):151-8. PubMed ID: 19003389
[TBL] [Abstract][Full Text] [Related]
2. Kinetics of retroviral production from the amphotropic ΨCRIP murine producer cell line.
Shen BQ; Clarke MF; Palsson BO
Cytotechnology; 1996 Jan; 22(1-3):185-95. PubMed ID: 22358929
[TBL] [Abstract][Full Text] [Related]
3. Comparison of different bioreactor systems for the production of high titer retroviral vectors.
Merten OW; Cruz PE; Rochette C; Geny-Fiamma C; Bouquet C; Gonçalves D; Danos O; Carrondo MJ
Biotechnol Prog; 2001; 17(2):326-35. PubMed ID: 11312711
[TBL] [Abstract][Full Text] [Related]
4. Retroviral end-point titer is not predictive of gene transfer efficiency: implications for vector production.
Forestell SP; Böhnlein E; Rigg RJ
Gene Ther; 1995 Dec; 2(10):723-30. PubMed ID: 8750011
[TBL] [Abstract][Full Text] [Related]
5. Closed hollow-fiber bioreactor: a new approach to retroviral vector production.
Pan D; Whitley CB
J Gene Med; 1999; 1(6):433-40. PubMed ID: 10753069
[TBL] [Abstract][Full Text] [Related]
6. Experimental and modelling study of different process modes for retroviral production in a fixed bed reactor.
Nehring D; Gonzalez R; Pörtner R; Czermak P
J Biotechnol; 2006 Mar; 122(2):239-53. PubMed ID: 16298006
[TBL] [Abstract][Full Text] [Related]
7. Large-scale clinical-grade retroviral vector production in a fixed-bed bioreactor.
Wang X; Olszewska M; Qu J; Wasielewska T; Bartido S; Hermetet G; Sadelain M; Rivière I
J Immunother; 2015 Apr; 38(3):127-35. PubMed ID: 25751502
[TBL] [Abstract][Full Text] [Related]
8. Retroviral vector production using suspension-adapted 293GPG cells in a 3L acoustic filter-based perfusion bioreactor.
Ghani K; Garnier A; Coelho H; Transfiguracion J; Trudel P; Kamen A
Biotechnol Bioeng; 2006 Nov; 95(4):653-60. PubMed ID: 16947907
[TBL] [Abstract][Full Text] [Related]
9. Continuous production process of retroviral vector for adoptive T- cell therapy.
Inwood S; Xu H; Black MA; Betenbaugh MJ; Feldman S; Shiloach J
Biochem Eng J; 2018 Apr; 132():145-151. PubMed ID: 29977134
[TBL] [Abstract][Full Text] [Related]
10. Production of high-titer retroviral vectors and detection of replication-competent retroviruses.
Kim YS; Lim HK; Kim KJ
Mol Cells; 1998 Feb; 8(1):36-42. PubMed ID: 9571629
[TBL] [Abstract][Full Text] [Related]
11. Production of retrovirus and adenovirus vectors for gene therapy: a comparative study using microcarrier and stationary cell culture.
Wu SC; Huang GY; Liu JH
Biotechnol Prog; 2002; 18(3):617-22. PubMed ID: 12052081
[TBL] [Abstract][Full Text] [Related]
12. Retroviral vector production under serum deprivation: The role of lipids.
Rodrigues AF; Carmo M; Alves PM; Coroadinha AS
Biotechnol Bioeng; 2009 Dec; 104(6):1171-81. PubMed ID: 19655394
[TBL] [Abstract][Full Text] [Related]
13. Effects of culture parameters on the production of retroviral vectors by a human packaging cell line.
McTaggart S; Al-Rubeai M
Biotechnol Prog; 2000; 16(5):859-65. PubMed ID: 11027182
[TBL] [Abstract][Full Text] [Related]
14. HEK293-based production platform for γ-retroviral (self-inactivating) vectors: application for safe and efficient transfer of COL7A1 cDNA.
Hennig K; Raasch L; Kolbe C; Weidner S; Leisegang M; Uckert W; Titeux M; Hovnanian A; Kuehlcke K; Loew R
Hum Gene Ther Clin Dev; 2014 Dec; 25(4):218-28. PubMed ID: 25381930
[TBL] [Abstract][Full Text] [Related]
15. The use of recombinase mediated cassette exchange in retroviral vector producer cell lines: predictability and efficiency by transgene exchange.
Coroadinha AS; Schucht R; Gama-Norton L; Wirth D; Hauser H; Carrondo MJ
J Biotechnol; 2006 Jul; 124(2):457-68. PubMed ID: 16529836
[TBL] [Abstract][Full Text] [Related]
16. Optimized conditions for the production of recombinant amphotropic retroviral vector preparations.
Kaptein LC; Greijer AE; Valerio D; van Beusechem VW
Gene Ther; 1997 Feb; 4(2):172-6. PubMed ID: 9081708
[TBL] [Abstract][Full Text] [Related]
17. Packaging cell line characteristics and optimizing retroviral vector titer: the National Gene Vector Laboratory experience.
Reeves L; Smucker P; Cornetta K
Hum Gene Ther; 2000 Oct; 11(15):2093-103. PubMed ID: 11044911
[TBL] [Abstract][Full Text] [Related]
18. Production of high-titer helper virus-free retroviral vectors by cocultivation of packaging cells with different host ranges.
Lynch CM; Miller AD
J Virol; 1991 Jul; 65(7):3887-90. PubMed ID: 2041097
[TBL] [Abstract][Full Text] [Related]
19. Culture media selection and feeding strategy for high titer production of a lentiviral vector by stable producer clones cultivated at high cell density.
Shen CF; Tremblay S; Sabourin-Poirier C; Burney E; Broussau S; Manceur A; Rodenbrock A; Voyer R; Loignon M; Ansorge S; Gilbert R
Bioprocess Biosyst Eng; 2022 Aug; 45(8):1267-1280. PubMed ID: 35758994
[TBL] [Abstract][Full Text] [Related]
20. Optimization of environmental factors for the production and handling of recombinant retrovirus.
Lee SG; Kim S; Robbins PD; Kim BG
Appl Microbiol Biotechnol; 1996 May; 45(4):477-83. PubMed ID: 8737571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
